This example shows the definition and results for a single analysis, "Summary of Subjects by Treatment and Sex", including the definitions of the grouping factors and method referenced by the analysis:
Lines 1-31: | Show the definitions of the 2 grouping factors referenced by the analysis, both of which are not data-driven (dataDriven = false, shown on lines 3 and 17):
|
Lines 32-44: | Show the definition of the method referenced by the analysis, "Summary by group of a categorical variable", which has 2 operations:
|
Lines 46-58: | Show the definition of the analysis:
|
Lines 59-155 | Show the list of results for the analysis. Each entry in the list (the start of which is indicated by a leading hyphen) represents an instance of the OperationResult class and contains:
|
analysisGroupings: - id: AnlsGrouping_01_Trt dataDriven: false label: Treatment groupingVariable: TRT01A groups: - id: AnlsGrouping_01_Trt_1 label: Placebo order: 1 ... - id: AnlsGrouping_01_Trt_2 label: Xanomeline Low Dose order: 2 ... - id: AnlsGrouping_01_Trt_3 label: Xanomeline High Dose order: 3 ... dataGroupings: - id: AnlsGrouping_06_Soc dataDriven: true label: System Organ Class groupingVariable: AESOC - id: AnlsGrouping_07_Pt dataDriven: true label: Preferred Term groupingVariable: AEDECOD methods: - id: Mth01_CatVar_Summ_ByGrp name: Summary by group of a categorical variable operations: - id: Mth01_CatVar_Summ_ByGrp_1_n name: Count of subjects label: n resultPattern: XXX - id: Mth01_CatVar_Summ_ByGrp_2_pct name: Percent of subjects label: '%' resultPattern: ( XX.X) ... analyses: - id: An07_10_SocPt_Summ_ByTrt name: Summary of Subjects with TEAEs by Treatment, System Organ Class and Preferred Term version: 1 dataset: ADAE variable: USUBJID methodId: Mth01_CatVar_Summ_ByGrp orderedGroupings: - order: 1 resultsByGroup: true groupingId: AnlsGrouping_01_Trt - order: 2 resultsByGroup: true groupingId: AnlsGrouping_06_Soc - order: 3 resultsByGroup: true groupingId: AnlsGrouping_07_Pt results: - operationId: Mth01_CatVar_Summ_ByGrp_1_n resultGroups: - groupingId: AnlsGrouping_01_Trt groupId: AnlsGrouping_01_Trt_1 - groupingId: AnlsGrouping_06_Soc groupValue: CARDIAC DISORDERS - groupingId: AnlsGrouping_07_Pt groupValue: ATRIAL FIBRILLATION rawValue: '1' formattedValue: '1' - operationId: Mth01_CatVar_Summ_ByGrp_2_pct resultGroups: - groupingId: AnlsGrouping_01_Trt groupId: AnlsGrouping_01_Trt_1 - groupingId: AnlsGrouping_06_Soc groupValue: CARDIAC DISORDERS - groupingId: AnlsGrouping_07_Pt groupValue: ATRIAL FIBRILLATION rawValue: '1.1628' formattedValue: ( 1.2) - operationId: Mth01_CatVar_Summ_ByGrp_1_n resultGroups: - groupingId: AnlsGrouping_01_Trt groupId: AnlsGrouping_01_Trt_1 - groupingId: AnlsGrouping_06_Soc groupValue: CARDIAC DISORDERS - groupingId: AnlsGrouping_07_Pt groupValue: ATRIAL FLUTTER rawValue: '0' formattedValue: '0' - operationId: Mth01_CatVar_Summ_ByGrp_2_pct resultGroups: - groupingId: AnlsGrouping_01_Trt groupId: AnlsGrouping_01_Trt_1 - groupingId: AnlsGrouping_06_Soc groupValue: CARDIAC DISORDERS - groupingId: AnlsGrouping_07_Pt groupValue: ATRIAL FLUTTER rawValue: '0' formattedValue: ( 0.0) - operationId: Mth01_CatVar_Summ_ByGrp_1_n resultGroups: - groupingId: AnlsGrouping_01_Trt groupId: AnlsGrouping_01_Trt_1 - groupingId: AnlsGrouping_06_Soc groupValue: CONGENITAL, FAMILIAL AND GENETIC DISORDERS - groupingId: AnlsGrouping_07_Pt groupValue: VENTRICULAR SEPTAL DEFECT rawValue: '0' formattedValue: '0' - operationId: Mth01_CatVar_Summ_ByGrp_2_pct resultGroups: - groupingId: AnlsGrouping_01_Trt groupId: AnlsGrouping_01_Trt_1 - groupingId: AnlsGrouping_06_Soc groupValue: CONGENITAL, FAMILIAL AND GENETIC DISORDERS - groupingId: AnlsGrouping_07_Pt groupValue: VENTRICULAR SEPTAL DEFECT rawValue: '0' formattedValue: ( 0.0) - operationId: Mth01_CatVar_Summ_ByGrp_1_n resultGroups: - groupingId: AnlsGrouping_01_Trt groupId: AnlsGrouping_01_Trt_1 - groupingId: AnlsGrouping_06_Soc groupValue: EAR AND LABYRINTH DISORDERS - groupingId: AnlsGrouping_07_Pt groupValue: CERUMEN IMPACTION rawValue: '0' formattedValue: '0' - operationId: Mth01_CatVar_Summ_ByGrp_2_pct resultGroups: - groupingId: AnlsGrouping_01_Trt groupId: AnlsGrouping_01_Trt_1 - groupingId: AnlsGrouping_06_Soc groupValue: EAR AND LABYRINTH DISORDERS - groupingId: AnlsGrouping_07_Pt groupValue: CERUMEN IMPACTION rawValue: '0' formattedValue: ( 0.0) ... ...
The results for this analysis could be represented in tabular format as shown in the following table, where the groupingId and groupId values from the 2 two instances of the ResultGroup class found in the resultGroups attribute for each each result are represented in separate pairs of columns ("groupingId1"/"groupId1" and "groupingId2"/"groupId2") so that each result is represented on a single row:
operationId | groupingId1 | groupId1 | groupingId2 | groupId2 | rawValue | formattedValue |
---|---|---|---|---|---|---|
Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 33 | 33 |
Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 53 | 53 |
Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 34 | 34 |
Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 50 | 50 |
Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 44 | 44 |
Mth01_CatVar_Summ_ByGrp_1_n | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 40 | 40 |
Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 38.3720930232558 | ( 38.4) |
Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_1 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 61.6279069767442 | ( 61.6) |
Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 40.4761904761905 | ( 40.5) |
Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_2 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 59.5238095238095 | ( 59.5) |
Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_1 | 52.3809523809524 | ( 52.4) |
Mth01_CatVar_Summ_ByGrp_2_pct | AnlsGrouping_01_Trt | AnlsGrouping_01_Trt_3 | AnlsGrouping_02_Sex | AnlsGrouping_02_Sex_2 | 47.6190476190476 | ( 47.6) |
operationId | operation_label | groupingId1 | grouping_label1 | groupId1 | group_label1 | groupingId2 | grouping_label2 | groupId2 | group_label2 | rawValue | formattedValue |
---|---|---|---|---|---|---|---|---|---|---|---|
Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 33 | 33 |
Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 53 | 53 |
Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 34 | 34 |
Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 50 | 50 |
Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 44 | 44 |
Mth01_CatVar_Summ_ByGrp_1_n | n | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 40 | 40 |
Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 38.3720930232558 | ( 38.4) |
Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_1 | Placebo | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 61.6279069767442 | ( 61.6) |
Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 40.4761904761905 | ( 40.5) |
Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_2 | Xanomeline Low Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 59.5238095238095 | ( 59.5) |
Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_1 | Male | 52.3809523809524 | ( 52.4) |
Mth01_CatVar_Summ_ByGrp_2_pct | % | AnlsGrouping_01_Trt | Treatment | AnlsGrouping_01_Trt_3 | Xanomeline High Dose | AnlsGrouping_02_Sex | Sex | AnlsGrouping_02_Sex_2 | Female | 47.6190476190476 | ( 47.6) |